02:38Why Ozempic keeps wowing the world | ABC News Daily podcast
From the creator
GLP-1 drugs were first approved to treat diabetes and then caused a frenzy when it was discovered they were great for weight loss. But now scientists are discovering the drugs that have brand names including Ozempic and Mounjaro might offer so much more, from reducing the risk of heart attack to treating kidney disease. Today, Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University on how Ozempic is shaking things up, again. Featured: Doctor Paul Joyce, a pharmaceutical scientist at Adelaide University
Published 2026-06-14 · Watch on YouTube ↗
Availability and playback restrictions are controlled by the original channel.
Keep exploring News
02:38
02:38
02:06‘Trump’s exit strategy may depend on quietly lifting Iran blockade’ | AJ #shorts
Al Jazeera English
05:26Israeli attacks kill two Palestinians in Gaza as ceasefire violations continue
Al Jazeera English
06:29Brief: Israel's launches first ground operation in Gaza since ceasefire | The Take
Al Jazeera English
01:40
02:02